FDA Shortens Moderna COVID-19 Booster Vaccination Interval to 5 Months

The United States Food and Drug Administration (FDA) has shortened the interval for getting a booster vaccination for the Moderna novel coronavirus (COVID-19) vaccine to 5 months.  FDA notes that vaccination is the best defense against COVID-19, including the circulating variants, and shortening the length of time between completion of a primary series and a booster dose may help reduce waning immunity.  To read the FDA announcement and summary of its shortening the Moderna COVID-19 booster vaccination interval to 5 months, use the link below.